Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Alzheimer Disease × birtamimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Immunoglobulin Light-chain Amyloidosis 4 Paraproteinemias 1 Amyloidosis 1 Alzheimer Disease 1

Interventions

birtamimab 1 Rosiglitazone 1 Melphalan 1 Magnetic Resonance Imaging 1 Dexamethasone 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02632786 2019-04-05

PRONTO

Prothena Biosciences Ltd.

Phase 2 Completed

129 enrolled 18 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡